Annual Conference International Society for Pharmacoepidemiology
ICPE All AccessVirtual Event ( September 16-17, 2020)
We are pleased to announce that PHARMO will present their study ‘Infliximab Use in the Netherlands: Uptake And Characteristics Of Originator And Biosimilars Over Time’ at the ICPE All Access Virtual Event (September 16-17, 2020)
The study will be presented by Jetty A. Overbeek, PhD and this presentation will be available on demand for ICPE registered attendees (click here for presentation and abstract).
The abstract of this study is also available for non-registered visitors.
Another study with PHARMO data that will be presented at the ICPE All Access Virtual Event is: Non-vitamin K Antagonist Oral Anticoagulant And Proton-pump Inhibitor Cotreatment And The Association With Upper Gastrointestinal Bleeds In Patients With Atrial Fibrillation: A Multi-database Cohort Study (presented by Joris Komen/University of Utrecht) (click here for presentation).
Besides these oral presentations you can also find posters of the following studies with PHARMO data at the ICPE website:
• A Multinational European Study of Anaphylaxis Among Recipients of Intravenous Iron
• Cardiorenal disease is the most common first cardiovascularmanifestation in type 2 diabetes and associated with increased mortality
• Incidence of Acute Pancreatitis among Daluglutide Initiators: – Results from a Post Authorization Safety Study (pass)
• Incidence of Arrhythmia And Cardiac Conduction Disorder Among Dulaglutide initiators: – Results From A Multi-Country Post Authorization Safety Study (pass)
• Comorbidities and characteristics in a cohort of patients with NAFLD/NASH from the Netherlands
• Proton pump inhibitors are not associated with an increased risk of colorectal cancer
• The PHARMO DIAbetes, MANagement and Treatment (DIAMANT) cohort: a population-based cohort of people with type 2 diabetes
• Adherence and persistence of once versus twice-daily direct oral anticoagulants
• How Marketing Approval Changed The Use Of Tranylcypromine in The Netherlands
• Impact of exposure misclassifcation due to information from differrent prescribers on the risk of bleeding associated with DOACs
• Sex Differences In Hospital Admissions Related To Adverse Drug Reactions (Linda Hendriksen)
• To What Extent Are Tropical Tacrolimus Or Pimecrolimus Associated With Increased Risk Of Skin Cancer And Lymphoma? Long-term Results From Joelle Study
• Data Sources For Studying Genetic Factors Of Chronic Obstructive Pulmonary Diseas (COPD)
All posters can be viewed by clicking this link.
The International Society for Pharmacoepidemiology (ISPE) is a non-profit international professional membership organization dedicated to advancing the health of the public by providing a forum for the open exchange of scientific information and for the development of policy; education; and advocacy for the field of pharmacoepidemiology, including pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management.